Mode of Action of Ondansetron, a 5-HT Receptor 3 Antagonist, in Lactulose Induced Diarrhoea

计划入组 16 人 · 首次发布于 2019 年 2 月 7 日

5-HT RBD REM Sleep Behavior Disorder

计划入组 66 人 · 首次发布于 2024 年 6 月 21 日

PET Imaging of Brain 5-HT(1A) Receptors Using [(11)C](-)-RWAY

计划入组 15 人 · 首次发布于 2005 年 12 月 8 日

AR-11-6081

SUN-N5147

ACP-106

Center 5

United States

Hangzhou MTR Line 5 Corporation Limited

China

A&A SMALL CHANGES HANDYPEOPLE

United States

Enveric Biosciences Publishes Breakthrough Research on Microbial Bioproduction of Neuropsychiatric Compounds

Enveric Biosciences Secures Patent Victory as AbbVie Withdraws Challenge Following $1.2 Billion Gilgamesh Acquisition

Enveric Biosciences Secures Fourth Patent for Non-Hallucinogenic Neuroplastogenic Drug Candidates